Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Manganese sulfate monohydrate

Manganese sulfate monohydrate

pharmaceutical raw materials
Manganese sulfate monohydrate structure

Manganese sulfate monohydrate 

structure
  • CAS No:

    10034-96-5

  • Formula:

    H2O4S.H2O.Mn

  • Chemical Name:

    Manganese sulfate monohydrate

  • Synonyms:

    Sulfuric acid,manganese(2+) salt,hydrate (1:1:1);Sulfuric acid,manganese(2+) salt (1:1),monohydrate;Manganese mesosulfate (MnSO4.H2O);Manganese sulfate (MnSO4) monohydrate;Manganese(2+) sulfate monohydrate;Manganese sulfate monohydrate;Manganese monosulfate monohydrate;Sulfuric acid manganese salt (1:1) monohydrate;Manganous sulfate monohydrate;Manganese(II) sulfate monohydrate;2360969-81-7;2485018-50-4

  • Categories:

    Active Pharmaceutical Ingredients  >  Vitamins and Minerals Medicines

Description

PINK HYGROSCOPIC CRYSTALS.


Manganese(ii) sulfate monohydrate appears as odorless pale red slightly efflorescent crystals or light pink powder. pH (5% solution) 3.7. (NTP, 1992)|PINK HYGROSCOPIC CRYSTALS.


Manganese(ii) sulfate monohydrate appears as odorless pale red slightly efflorescent crystals or light pink powder. pH (5% solution) 3.7. (NTP, 1992)|Manganese(II) sulfate monohydrate is a hydrate that is the monohydrate form of manganese(II) sulfate. It has a role as a nutraceutical. It is a hydrate, a manganese molecular entity and a metal sulfate. It contains a manganese(II) sulfate.

Manganese sulfate monohydrate Basic Attributes

169.02

168.900345

232-089-9

W00LYS4T26

0290

3077

DTXSID4020795

28332990

Characteristics

89.6

-0.32150

Pink Solid

2.95 g/cm3

700 °C

850 °C

H2O: 5-10 g/100 mL at 21 ºC

Store at RT.

3.35E-05mmHg at 25°C

Combustible, the fire emits manganese, sulfur oxides and spicy irritating smoke

Water soluble. Hygroscopic.

Salts, Acidic

MANGANESE(II) SULFATE MONOHYDRATE is incompatible with aluminum and magnesium. (NTP, 1992)

Safety Information

9

UN 3077 9/PG 3

1

48/20/22-51/53

22-61

OP0893500

Xn,N

Warehouse low temperature, ventilated, dry

Stable under normal temperatures and pressures.

P273

H373-H411

Flash point data for this chemical are not available; however, it is probably combustible. (NTP, 1992)|Not combustible. Gives off irritating or toxic fumes (or gases) in a fire.

|Warning|H373 (99.87%): Causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]|P260, P273, P314, P391, and P501|Aggregated GHS information provided by 1572 companies from 15 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.|H373 (100%): Causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]|Aggregated GHS information provided by 42 companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.|Danger|H302: Harmful if swallowed [Warning Acute toxicity, oral]|P260, P264, P270, P280, P301+P312, P305+P351+P338, P310, P314, P330, and P501|H341: Suspected of causing genetic defects [Warning Germ cell mutagenicity]|P201, P202, P281, P308+P313, P405, and P501|P201, P202, P260, P264, P270, P280, P281, P301+P312, P305+P351+P338, P308+P313, P310, P314, P330, P405, and P501

Fires involving this material can be controlled with a dry chemical, carbon dioxide or Halon extinguisher. A water spray may also be used. (NTP, 1992)|In case of fire in the surroundings, use appropriate extinguishing media.

Excerpt from ERG Guide 171 [Substances (Low to Moderate Hazard)]: As an immediate precautionary measure, isolate spill or leak area in all directions for at least 50 meters (150 feet) for liquids and at least 25 meters (75 feet) for solids. SPILL: Increase, in the downwind direction, as necessary, the isolation distance shown above. FIRE: If tank, rail car or tank truck is involved in a fire, ISOLATE for 800 meters (1/2 mile) in all directions; also, consider initial evacuation for 800 meters (1/2 mile) in all directions. (ERG, 2016)

SMALL SPILLS AND LEAKAGE: If you spill this chemical, you should dampen the solid spill material with water, then transfer the dampened material to a suitable container. Use absorbent paper dampened with water to pick up any remaining material. Seal your contaminated clothing and the absorbent paper in a vapor-tight plastic bag for eventual disposal. Wash all contaminated surfaces with a soap and water solution. Do not reenter the contaminated area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned. STORAGE PRECAUTIONS: You should store this chemical under ambient temperatures, and protect it from moisture. If possible, it would be prudent to store this compound under inert atmosphere. (NTP, 1992)

RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with an organic vapor/acid gas cartridge (specific for organic vapors, HCl, acid gas and SO2) with a dust/mist filter. (NTP, 1992)

Personal protection: particulate filter respirator adapted to the airborne concentration of the substance. Do NOT let this chemical enter the environment. Sweep spilled substance into covered containers. If appropriate, moisten first to prevent dusting. Wash away remainder with plenty of water. Store and dispose of according to local regulations.

Dry. Well closed. Store in an area without drain or sewer access.

Evaporation at 20 °C is negligible; a harmful concentration of airborne particles can, however, be reached quickly when dispersed, especially if powdered.

The substance is irritating to the eyes.

The substance may have effects on the central nervous system. Animal tests show that this substance possibly causes toxicity to human reproduction or development.

PREVENT DISPERSION OF DUST!

Use local exhaust or breathing protection.

Protective gloves.

Wear safety spectacles or eye protection in combination with breathing protection if powder.

Toxicity

moderately toxic

Drug Information

SYMPTOMS: Symptoms of exposure to this compound include mild irritation of the eyes and mucous membranes of the respiratory tract. Symptoms of exposure to this type of compound include apathy, anorexia, headache, recurring leg cramps, loss of balance, clumsiness, pneumonia and associated pulmonary problems. Other symptoms include central nervous system damage, pulmonary system damage, upper respiratory infections, languor, sleepiness, weakness in the legs, a stolid, mask-like face, muscular twitchings, varying from a fine tremor of the hands to coarse, rhythmical movements of the arms, legs and trunk; slight increase in tendon reflexes, ankle and patellar clonus, typical Parkinsonian slapping gait and minute handwriting (affected by micrographia). It can cause spastic gait, insomnia, dystonia, fatiguability, asthenia and an inability to concentrate. It can also cause impaired mentation, ataxia, difficulty in walking and decreased movement of the eyelids and eyes. Other symptoms include lethargy, edema, extrapyramidal effects, sleep disturbances, dermatitis, irritability, liver enlargement, increased muscle tone, muscular cramps, mental deterioration, excessive salivation and perspiration, sexual disturbances, blood changes and, very rarely, hypothyroidism. Exposure can cause spasms, arthralgias and speech disturbances such as slurred speech, slow and monotonous voice tone, inability to speak above a whisper, difficult articulation and incoherence, and even complete muteness. Psychosis may occur with unaccountable laughter, euphoria, impulsive acts, absentmindedness, mental confusion, aggressiveness and hallucinations. Propulsion, retropropulsion and lateropropulsion are affected with no movement for protection when falling. Absolute detachment may occur, broken by sporadic or spasmodic laughter. Inhalation may cause acute bronchitis, nasopharyngitis and itching. Numbness of the extremities and impairment of libido may occur. Other effects include weakness, delusions, compulsions, rigidity, bradykinesia, sudden crying, stuttering, hoarse voice, nervousness, inability to walk backward, hyporeflexia, Romberg's sign, adiadochokinesia, forgetfulness, general malaise, drowsiness, stiffness of the arms or legs, urinary difficulty, somnolence, sexual excitement followed by impotence, "hen's gait" and frequent falling. Fever may occur, with chills, upset stomach (nausea), vomiting, dryness of the throat, cough and body aches. Other symptoms include trouble with memory and judgment, unstable emotions, incoordination, chest pain, restlessness, double vision, impaired hearing, anemia, lassitude and low back pain. Symptoms of exposure may simulate progressive bulbar paralysis, post-encephalitic Parkinsonism, multiple sclerosis, amyotrophic lateral sclerosis and progressive lenticular degeneration (Wilson's Disease). ACUTE/CHRONIC HAZARDS: When heated to decomposition this compound emits toxic fumes of sulfur oxides. (NTP, 1992)

EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop. SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment. INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. If symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop, call a physician and be prepared to transport the victim to a hospital. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA) should be used; if not available, use a level of protection greater than or equal to that advised under Protective Clothing. INGESTION: DO NOT INDUCE VOMITING. If the victim is conscious and not convulsing, give 1 or 2 glasses of water to dilute the chemical and IMMEDIATELY call a hospital or poison control center. Be prepared to transport the victim to a hospital if advised by a physician. If the victim is convulsing or unconscious, do not give anything by mouth, ensure that the victim's airway is open and lay the victim on his/her side with the head lower than the body. DO NOT INDUCE VOMITING. IMMEDIATELY transport the victim to a hospital. (NTP, 1992)


Fresh air, rest.


Rinse with plenty of water for several minutes (remove contact lenses if easily possible).

manganese sulfate

The substance can be absorbed into the body by inhalation of its aerosol and by ingestion.

Cough. Sore throat. Shortness of breath.


Redness. Pain.

Manganese sulfate monohydrate Use and Manufacturing

Methods of Manufacturing

Mix manganese ore and white coal powder with MnO2 content of more than 65% at a ratio of 100:20 (mass ratio), and roast at 700-850°C in a reduction roaster to obtain manganese monoxide. After cooling, MnO is acidolyzed in 15% sulfuric acid to control PH<5.2, the acidolysis solution is adjusted to PH=3-4, metered barium sulfide is added to remove heavy metals, and the hydroxide precipitate and slag are removed by pressure filtration. After standing for 48h, filter again to remove impurities. The filtrate is finally concentrated, crystallized, separated and dried by hot air to obtain manganese sulfate.

Uses

Manganese(II) sulfate is used to produce manganese by an electrolytic process. The compound is used for dyeing textiles; for producing red glazes on porcelain; in varnish driers; in fertilizers; and in animal feeds to provide manganese as an essential trace element.

Computed Properties

Molecular Weight:169.02
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:5
Exact Mass:168.900337
Monoisotopic Mass:168.900337
Topological Polar Surface Area:89.6
Heavy Atom Count:7
Complexity:62.2
Covalently-Bonded Unit Count:3
Compound Is Canonicalized:Yes

Downstream Products

Drug Function and Efficacy

Manganese is a component of many metalloenzymes and an enzyme activator. Manganese depletion is associated with a significant decrease in soft tissue chondroitin sulfate.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • METROCHEM API PRIVATE LTD

    United States United States
    Active
  • MAITHRI DRUGS PRIVATE LTD

    United States United States
    Active
  • BIOPHORE INDIA PHARMACEUTICALS PVT LTD

    United States United States
    Active

Recommended Suppliers of Manganese sulfate monohydrate

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.